MAPT and tauopathy: To further test the therapeutic benefits of these anti-tau sdAbs, we crossed the lines into a Drosophila model of tauopathy that features a pan-neuronal expression of tauR406W [16], a mutant form of human tau that underlies a familial form of frontotemporal dementia [25].